Immune modulation and graft protection by gene therapy in kidney transplantation

European Journal of Pharmacology

Volumn 585, Issue 2-3, 2008, Pages 261-269

  Sandovici, Maria ^a   Deelman, Leo E ^a   de Zeeuw, Dick ^a   van Goor, Harry ^a   Henning, Robert H ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Acute rejection; Chronic transplant dysfunction; Gene therapy; Gene transfer; Ischemia reperfusion injury; Kidney; Tolerance; Transplantation

Indexed keywords

ABATACEPT; CASPASE 3; COMPLEMENT COMPONENT C3; COPPER ZINC SUPEROXIDE DISMUTASE; CYTOKINE; CYTOKINE RECEPTOR; FAS ANTIGEN; FAS LIGAND; GAMMA INTERFERON; HEAT SHOCK PROTEIN 70; HEME OXYGENASE 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 12P40; INTERLEUKIN 13; INTERLEUKIN 4; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MITOGEN ACTIVATED PROTEIN KINASE 1; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTEIN BCL 2; PROTEIN TNFRP55IG; SCATTER FACTOR; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA3;

ACUTE GRAFT REJECTION; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; CELL PROTECTION; CLONAL ANERGY; DRUG EFFECT; DRUG INHIBITION; GENE TARGETING; GENE THERAPY; GENETIC TRANSDUCTION; GRAFT FAILURE; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; KIDNEY FUNCTION; KIDNEY ISCHEMIA; KIDNEY TRANSPLANTATION; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PRIORITY JOURNAL; REPERFUSION INJURY; REVIEW; T LYMPHOCYTE; VIRAL GENE DELIVERY SYSTEM;

ANIMALS; GENE THERAPY; GENETIC VECTORS; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSION; KIDNEY TRANSPLANTATION; REGENERATION; REPERFUSION INJURY;

EID: 43049125832     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2008.02.087     Document Type: Review

References (78)

1. Alexander A.M., Crawford M., Bertera S., Rudert W.A., Takikawa O., Robbins P.D., and Trucco M. Indoleamine 2,3-dioxygenase expression in transplanted NOD islets prolongs graft survival after adoptive transfer of diabetogenic splenocytes. Diabetes 51 (2002) 356-365
2. Arumugam T.V., Shiels I.A., Woodruff T.M., Granger D.N., and Taylor S.M. The role of the complement system in ischemia-reperfusion injury. Shock 21 (2004) 401-409
3. Azuma H., Tomita N., Kaneda Y., Koike H., Ogihara T., Katsuoka Y., and Morishita R. Transfection of NFkappaB-decoy oligodeoxynucleotides using efficient ultrasound-mediated gene transfer into donor kidneys prolonged survival of rat renal allografts. Gene Ther. 10 (2003) 415-425
4. Baeten D., Louis S., Braud C., Braudeau C., Ballet C., Moizant F., Pallier A., Giral M., Brouard S., and Soulillou J.P. Phenotypically and functionally distinct CD8+ lymphocyte populations in long-term drug-free tolerance and chronic rejection in human kidney graft recipients. J. Am. Soc. Nephrol. 17 (2006) 294-304
5. Benigni A., Tomasoni S., Turka L.A., Longaretti L., Zentilin L., Mister M., Pezzotta A., Azzollini N., Noris M., Conti S., Abbate M., Giacca M., and Remuzzi G. Adeno-associated virus-mediated CTLA4Ig gene transfer protects MHC-mismatched renal allografts from chronic rejection. J. Am. Soc. Nephrol. 17 (2006) 1665-1672
6. Blydt-Hansen T.D., Katori M., Lassman C., Ke B., Coito A.J., Iyer S., Buelow R., Ettenger R., Busuttil R.W., and Kupiec-Weglinski J.W. Gene transfer-induced local heme oxygenase-1 overexpression protects rat kidney transplants from ischemia/reperfusion injury. J. Am. Soc. Nephrol. 14 (2003) 745-754
7. Bonventre J.V., and Zuk A. Ischemic acute renal failure: an inflammatory disease?. Kidney Int. 66 (2004) 480-485
8. Brodsky S.V., Yamamoto T., Tada T., Kim B., Chen J., Kajiya F., and Goligorsky M.S. Endothelial dysfunction in ischemic acute renal failure: rescue by transplanted endothelial cells. Am. J. Physiol., Renal Fluid Electrolyte Physiol. 282 (2002) F1140-F1149
9. Buell J.F., Gross T.G., and Woodle E.S. Malignancy after transplantation. Transplantation 80 (2005) S254-S264
10. Callaghan C.J., and Bradley J.A. Current status of renal transplantation. Methods Mol. Biol. 333 (2006) 1-28
11. Cao C.C., Ding X.Q., Ou Z.L., Liu C.F., Li P., Wang L., and Zhu C.F. In vivo transfection of NF-kappaB decoy oligodeoxynucleotides attenuate renal ischemia/reperfusion injury in rats. Kidney Int. 65 (2004) 834-845
12. Chai J.G., Xue S.A., Coe D., Addey C., Bartok I., Scott D., Simpson E., Stauss H.J., Hori S., Sakaguchi S., and Dyson J. Regulatory T cells, derived from naive CD4+. Transplantation 79 (2005) 1310-1316
13. Chapman J.R., O'Connell P.J., and Nankivell B.J. Chronic renal allograft dysfunction. J. Am. Soc. Nephrol. 16 (2005) 3015-3026
14. Deng J., Kohda Y., Chiao H., Wang Y., Hu X., Hewitt S.M., Miyaji T., McLeroy P., Nibhanupudy B., Li S., and Star R.A. Interleukin-10 inhibits ischemic and cisplatin-induced acute renal injury. Kidney Int. 60 (2001) 2118-2128
15. Dragun D., Lukitsch I., Tullius S.G., Qun Y., Park J.K., Schneider W., Luft F.C., and Haller H. Inhibition of intercellular adhesion molecule-1 with antisense deoxynucleotides prolongs renal isograft survival in the rat. Kidney Int. 54 (1998) 2113-2122
16. Dragun D., Tullius S.G., Park J.K., Maasch C., Lukitsch I., Lippoldt A., Gross V., Luft F.C., and Haller H. ICAM-1 antisense oligodesoxynucleotides prevent reperfusion injury and enhance immediate graft function in renal transplantation. Kidney Int. 54 (1998) 590-602
17. Fallarino F., Grohmann U., You S., McGrath B.C., Cavener D.R., Vacca C., Orabona C., Bianchi R., Belladonna M.L., Volpi C., Santamaria P., Fioretti M.C., and Puccetti P. The combined effects of tryptophan starvation and tryptophan catabolites down-regulate T cell receptor zeta-chain and induce a regulatory phenotype in naive T cells. J. Immunol. 176 (2006) 6752-6761
18. Franquesa M., Alperovich G., Herrero-Fresneda I., Lloberas N., Bolanos N., Fillat C., Rama I., Cruzado J.M., Grinyo J.M., and Torras J. Direct electrotransfer of hHGF gene into kidney ameliorates ischemic acute renal failure. Gene Ther. 12 (2005) 1551-1558
19. Freeman G.J., Long A.J., Iwai Y., Bourque K., Chernova T., Nishimura H., Fitz L.J., Malenkovich N., Okazaki T., Byrne M.C., Horton H.F., Fouser L., Carter L., Ling V., Bowman M.R., Carreno B.M., Collins M., Wood C.R., and Honjo T. Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J. Exp. Med. 192 (2000) 1027-1034
20. Furuichi K., Wada T., Iwata Y., Kitagawa K., Kobayashi K., Hashimoto H., Ishiwata Y., Tomosugi N., Mukaida N., Matsushima K., Egashira K., and Yokoyama H. Gene therapy expressing amino-terminal truncated monocyte chemoattractant protein-1 prevents renal ischemia-reperfusion injury. J. Am. Soc. Nephrol. 14 (2003) 1066-1071
21. Ghahary A., Li Y., Tredget E.E., Kilani R.T., Iwashina T., Karami A., and Lin X. Expression of indoleamine 2,3-dioxygenase in dermal fibroblasts functions as a local immunosuppressive factor. J. Invest. Dermatol. 122 (2004) 953-964
22. Gong N., Dong C., Chen Z., Chen X., Guo H., Zeng Z., Ming C., and Klaus C.Z. Adenovirus-mediated antisense-ERK2 gene therapy attenuates chronic allograft nephropathy. Transplant. Proc. 38 (2006) 3228-3230
23. Gorczynski R.M. Role of cytokines in allograft rejection. Curr. Pharm. Des. 7 (2001) 1039-1057
24. Gorczynski R.M., Bransom J., Cattral M., Huang X., Lei J., Xiaorong L., Min W.P., Wan Y., and Gauldie J. Synergy in induction of increased renal allograft survival after portal vein infusion of dendritic cells transduced to express TGFbeta and IL-10, along with administration of CHO cells expressing the regulatory molecule OX-2. Clin. Immunol. 95 (2000) 182-189
25. Grohmann U., Orabona C., Fallarino F., Vacca C., Calcinaro F., Falorni A., Candeloro P., Belladonna M.L., Bianchi R., Fioretti M.C., and Puccetti P. CTLA-4-Ig regulates tryptophan catabolism in vivo. Nat. Immunol. 3 (2002) 1097-1101
26. Halloran P.F. Immunosuppressive drugs for kidney transplantation. N. Engl. J. Med. 351 (2004) 2715-2729
27. Hamar P., Song E., Kokeny G., Chen A., Ouyang N., and Lieberman J. Small interfering RNA targeting Fas protects mice against renal ischemia-reperfusion injury. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 14883-14888
28. Hanss B., and Bruggeman L.A. Applications of gene therapy to kidney disease. Curr. Opin. Nephrol. Hypertens. 12 (2003) 439-445
29. Herrero-Fresneda I., Torras J., Franquesa M., Vidal A., Cruzado J.M., Lloberas N., Fillat C., and Grinyo J.M. HGF gene therapy attenuates renal allograft scarring by preventing the profibrotic inflammatory-induced mechanisms. Kidney Int. 70 (2006) 265-274
30. Huang C., Huang C., Hestin D., Dent P.C., Barclay P., Collis M., and Johns E.J. The effect of endothelin antagonists on renal ischaemia-reperfusion injury and the development of acute renal failure in the rat. Nephrol. Dial. Transplant. 17 (2002) 1578-1585
31. Isaka Y. Gene therapy targeting kidney diseases: routes and vehicles. Clin. Exp. Nephrol. 10 (2006) 229-235
32. Isaka Y., Yamada K., Takabatake Y., Mizui M., Miura-Tsujie M., Ichimaru N., Yazawa K., Utsugi R., Okuyama A., Hori M., Imai E., and Takahara S. Electroporation-mediated HGF gene transfection protected the kidney against graft injury. Gene Ther. 12 (2005) 815-820
33. Joosten S.A., Sijpkens Y.W., van Kooten C., and Paul L.C. Chronic renal allograft rejection: pathophysiologic considerations. Kidney Int. 68 (2005) 1-13
34. Kato H., Ritter T., Ke B., Murakami M., Kusano M., Busuttil R.W., and Kupiec-Weglinski J.W. Adenovirus-mediated gene transfer of IL-4 prolongs rat renal allograft survival and inhibits the p21(ras)-activation pathway. Transplant. Proc. 32 (2000) 245-246
35. Ke B., Coito A.J., Kato H., Zhai Y., Wang T., Sawitzki B., Seu P., Busuttil R.W., and Kupiec-Weglinski J.W. Fas ligand gene transfer prolongs rat renal allograft survival and down-regulates anti-apoptotic Bag-1 in parallel with enhanced Th2-type cytokine expression. Transplantation 69 (2000) 1690-1694
36. Kita J., Kobayashi E., Hishinuma A., and Kaneda Y. Genetic modification of cold-preserved renal grafts using HSP70 or bcl-2 HVJ-liposome method. Transpl. Immunol. 11 (2003) 7-14
37. Kotton C.N., and Fishman J.A. Viral infection in the renal transplant recipient. J. Am. Soc. Nephrol. 16 (2005) 1758-1774
38. Kouwenhoven E.A., de Bruin R.W., Bajema I.M., Marquet R.L., and Ijzermans J.N. Cold ischemia augments allogeneic-mediated injury in rat kidney allografts. Kidney Int. 59 (2001) 1142-1148
39. Mellor A.L., and Munn D.H. Tryptophan catabolism and regulation of adaptive immunity. J. Immunol. 170 (2003) 5809-5813
40. Montanaro D., Gropuzzo M., Tulissi P., Vallone C., Boscutti G., Mioni R., Risaliti A., Baccarani U., Adani G.L., Sainz M., Bresadola F., and Mioni G. Renoprotective effect of early inhibition of the renin-angiotensin system in renal transplant recipients. Transplant. Proc. 37 (2005) 991-993
41. Morales J.M., and Dominguez-Gil B. Cardiovascular risk profile with the new immunosuppressive combinations after renal transplantation. J. Hypertens. 23 (2005) 1609-1616
42. Munn D.H., Zhou M., Attwood J.T., Bondarev I., Conway S.J., Marshall B., Brown C., and Mellor A.L. Prevention of allogeneic fetal rejection by tryptophan catabolism. Science 281 (1998) 1191-1193
43. Muthukumar T., Dadhania D., Ding R., Snopkowski C., Naqvi R., Lee J.B., Hartono C., Li B., Sharma V.K., Seshan S.V., Kapur S., Hancock W.W., Schwartz J.E., and Suthanthiran M. Messenger RNA for FOXP3 in the urine of renal-allograft recipients. N. Engl. J. Med. 353 (2005) 2342-2351
44. Nagano H., Nadeau K.C., Takada M., Kusaka M., and Tilney N.L. Sequential cellular and molecular kinetics in acutely rejecting renal allografts in rats. Transplantation 63 (1997) 1101-1108
45. Nankivell B.J., and Chapman J.R. Chronic allograft nephropathy: current concepts and future directions. Transplantation 81 (2006) 643-654
46. Nankivell B.J., Borrows R.J., Fung C.L., O'Connell P.J., Allen R.D., and Chapman J.R. The natural history of chronic allograft nephropathy. N. Engl. J. Med. 349 (2003) 2326-2333
47. Nogae S., Miyazaki M., Kobayashi N., Saito T., Abe K., Saito H., Nakane P.K., Nakanishi Y., and Koji T. Induction of apoptosis in ischemia-reperfusion model of mouse kidney: possible involvement of Fas. J. Am. Soc. Nephrol. 9 (1998) 620-631
48. Opelz G., Wujciak T., Dohler B., Scherer S., and Mytilineos J. HLA compatibility and organ transplant survival. Collaborative Transplant Study. Rev. Immunogenet. 1 (1999) 334-342
49. Padanilam B.J. Cell death induced by acute renal injury: a perspective on the contributions of apoptosis and necrosis. Am. J. Physiol., Renal Fluid Electrolyte Physiol. 284 (2003) F608-F627
50. Patel R. Infections in recipients of kidney transplants. Infect. Dis. Clin. North Am. 15 (2001) 901-952
51. Perico N., Cattaneo D., Sayegh M.H., and Remuzzi G. Delayed graft function in kidney transplantation. Lancet 364 (2004) 1814-1827
52. Raz E., Watanabe A., Baird S.M., Eisenberg R.A., Parr T.B., Lotz M., Kipps T.J., and Carson D.A. Systemic immunological effects of cytokine genes injected into skeletal muscle. Proc. Natl. Acad. Sci. U. S. A. 90 (1993) 4523-4527
53. Sandovici M., Deelman L.E., Smit-van Oosten A., van Goor H., Rots M.G., de Zeeuw D., and Henning R.H. Enhanced transduction of fibroblasts in transplanted kidney with an adenovirus having an RGD motif in the HI loop. Kidney Int. 69 (2006) 45-52
54. Sandovici M., Deelman L.E., van Goor H., Helfrich W., de Zeeuw D., and Henning R.H. Adenovirus-mediated interleukin-13 gene therapy attenuates acute kidney allograft injury. J. Gene Med. 9 (2007) 1024-1032
55. Sandovici, M., Henning, R.H., van Goor, H., Helfrich, W., de Zeeuw, D., Deelman, L.E., in press. Systemic gene therapy with interleukin-13 attenuates renal ischemia-reperfusion injury. Kidney Int.
56. Sato M., and Keshavjee S. Gene therapy in lung transplantation. Curr. Gene Ther. 6 (2006) 439-458
57. Schiedner G., Morral N., Parks R.J., Wu Y., Koopmans S.C., Langston C., Graham F.L., Beaudet A.L., and Kochanek S. Genomic DNA transfer with a high-capacity adenovirus vector results in improved in vivo gene expression and decreased toxicity. Nat. Genet. 18 (1998) 180-183
58. Sonntag K.C., Emery D.W., Yasumoto A., Haller G., Germana S., Sablinski T., Shimizu A., Yamada K., Shimada H., Arn S., Sachs D.H., and LeGuern C. Tolerance to solid organ transplants through transfer of MHC class II genes. J. Clin. Invest. 107 (2001) 65-71
59. Stallone G., Infante B., Schena A., Battaglia M., Ditonno P., Loverre A., Gesualdo L., Schena F.P., and Grandaliano G. Rapamycin for treatment of chronic allograft nephropathy in renal transplant patients. J. Am. Soc. Nephrol. 16 (2005) 3755-3762
60. Starzl T.E. History of clinical transplantation. World J. Surg. 24 (2000) 759-782
61. Stubenitsky B.M., Booster M.H., Nederstigt A.P., Kievit J.K., Jacobs R.W., and Kootstra G. Kidney preservation in the next millenium. Transpl. Int. 12 (1999) 83-91
62. Swanson K.A., Zheng Y., Heidler K.M., Mizobuchi T., and Wilkes D.S. CDllc+ cells modulate pulmonary immune responses by production of indoleamine 2,3-dioxygenase. Am. J. Respir. Cell Mol. Biol. 30 (2004) 311-318
63. Swenson K.M., Ke B., Wang T., Markowitz J.S., Maggard M.A., Spear G.S., Imagawa D.K., Goss J.A., Busuttil R.W., and Seu P. Fas ligand gene transfer to renal allografts in rats: effects on allograft survival. Transplantation 65 (1998) 155-160
64. Takada M., Nadeau K.C., Shaw G.D., Marquette K.A., and Tilney N.L. The cytokine-adhesion molecule cascade in ischemia/reperfusion injury of the rat kidney. Inhibition by a soluble P-selectin ligand. J. Clin. Invest. 99 (1997) 2682-2690
65. Tanner G.A., Sloan K.L., and Sophasan S. Effects of renal artery occlusion on kidney function in the rat. Kidney Int. 4 (1973) 377-389
66. Tomasoni S., Azzollini N., Casiraghi F., Capogrossi M.C., Remuzzi G., and Benigni A. CTLA4Ig gene transfer prolongs survival and induces donor-specific tolerance in a rat renal allograft. J. Am. Soc. Nephrol. 11 (2000) 747-752
67. Tomasoni S., Longaretti L., Azzollini N., Gagliardini E., Mister M., Buehler T., Remuzzi G., and Benigni A. Favorable effect of cotransfection with TGF-beta and CTLA4Ig of the donor kidney on allograft survival. Am. J. Nephrol. 24 (2004) 275-283
68. Tomasoni S., Aiello S., Cassis L., Noris M., Longaretti L., Cavinato R.A., Azzollini N., Pezzotta A., Remuzzi G., and Benigni A. Dendritic cells genetically engineered with adenoviral vector encoding dnIKK2 induce the formation of potent CD4+ T-regulatory cells. Transplantation 79 (2005) 1056-1061
69. Truong W., Hancock W.W., Anderson C.C., Merani S., and Shapiro A.M. Coinhibitory T-cell signaling in islet allograft rejection and tolerance. Cell Transplant 15 (2006) 105-119
70. van der Wouden E.A., Sandovici M., Henning R.H., de Zeeuw D., and Deelman L.E. Approaches and methods in gene therapy for kidney disease. J. Pharmacol. Toxicol. Methods 50 (2004) 13-24
71. Vos I.H., Govers R., Grone H.J., Kleij L., Schurink M., De Weger R.A., Goldschmeding R., and Rabelink T.J. NFkappaB decoy oligodeoxynucleotides reduce monocyte infiltration in renal allografts. FASEB J. 14 (2000) 815-822
72. Walker L.M., York J.L., Imam S.Z., Ali S.F., Muldrew K.L., and Mayeux P.R. Oxidative stress and reactive nitrogen species generation during renal ischemia. Toxicol. Sci. 63 (2001) 143-148
73. Wolfe R.A., Ashby V.B., Milford E.L., Ojo A.O., Ettenger R.E., Agodoa L.Y., Held P.J., and Port F.K. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N. Engl. J. Med. 341 (1999) 1725-1730
74. Yang J., Reutzel-Selke A., Steier C., Jurisch A., Tullius S.G., Sawitzki B., Kolls J., Volk H.D., and Ritter T. Targeting of macrophage activity by adenovirus-mediated intragraft overexpression of TNFRp55-Ig, IL-12p40, and vIL-10 ameliorates adenovirus-mediated chronic graft injury, whereas stimulation of macrophages by overexpression of IFN-gamma accelerates chronic graft injury in a rat renal allograft model. J. Am. Soc. Nephrol. 14 (2003) 214-225
75. Yates P.J., and Nicholson M.L. The aetiology and pathogenesis of chronic allograft nephropathy. Transpl. Immunol. 16 (2006) 148-157
76. Yin M., Wheeler M.D., Connor H.D., Zhong Z., Bunzendahl H., Dikalova A., Samulski R.J., Schoonhoven R., Mason R.P., Swenberg J.A., and Thurman R.G. Cu/Zn-superoxide dismutase gene attenuates ischemia-reperfusion injury in the rat kidney. J. Am. Soc. Nephrol. 12 (2001) 2691-2700
77. Zheng X., Feng B., Chen G., Zhang X., Li M., Sun H., Liu W., Vladau C., Liu R., Jevnikar A.M., Garcia B., Zhong R., and Min W.P. Preventing renal ischemia-reperfusion injury using small interfering RNA by targeting complement 3 gene. Am. J. Transpl. 6 (2006) 2099-2108
78. Zheng X., Zhang X., Sun H., Feng B., Li M., Chen G., Vladau C., Chen D., Suzuki M., Min L., Liu W., Zhong R., Garcia B., Jevnikar A., and Min W.P. Protection of renal ischemia injury using combination gene silencing of complement 3 and caspase 3 genes. Transplantation 82 (2006) 1781-1786